Vulnerability and Risk of Neuropathic Pain in Cancer
Many cancer patients experience ongoing nerve pain, which can be hard to treat and significantly impact their lives. This study explores why some people are more likely to develop this pain after cancer treatments like surgery, chemotherapy, or radiotherapy. Researchers want to understand the different factors that might increase this risk, such as pre-existing pain, sleep problems, emotional well-being, and social circumstances. The main goal is to create a simple tool that doctors can use to predict a patient's risk of developing long-lasting nerve pain early on. This could help tailor care and potentially prevent pain from becoming a long-term issue, ultimately improving quality of life for cancer patients.
At a glance
What is this study about?
When people are treated for cancer, for example with surgery, chemotherapy, or radiotherapy, these treatments can sometimes cause pain. For many, this pain goes away, but for some, it can turn into long-lasting pain, often called neuropathic pain. This is a special type of pain that comes from damage to nerves.
This long-lasting nerve pain is common, affecting about half of all cancer patients. It can be very difficult to treat, often appearing slowly and sometimes lasting even after the cancer has gone. This can make everyday life much harder. Doctors currently use general guidelines to treat this pain, but these treatments don't always work, and sometimes they can have side effects.
Researchers understand that many different things can affect whether someone gets this long-lasting pain. These include how much pain they had before treatment, how old they are, if they have trouble sleeping, and their general emotional and mental state. This study aims to bring all this information together to better understand why some people are more vulnerable. The big goal is to develop a tool that healthcare teams can use early on to spot patients who might be at a higher risk of developing persistent nerve pain. This way, they can offer more targeted support and potentially prevent the pain from becoming a long-term problem.
Key takeaways
- Many cancer patients get long-lasting nerve pain.
- This study wants to find out why some people are more at risk.
- It aims to create a tool to predict this risk early on.
- Understanding these risks could lead to better pain prevention.
- Participation involves assessments, not new treatments.
Who may be eligible?
This study is looking for two main groups of people: adults (over 18) who have cancer, and healthy volunteers. If you have cancer, you might be able to join if you are going through treatment for breast, gynaecological, bowel (colorectal), or lung cancer, and you're having treatments like chemotherapy, surgery, hormone therapy, or radiotherapy.
However, you wouldn't be able to join if you've had cancer or cancer treatment in the past, or if you have certain brain tumours or other serious neurological conditions like Parkinson's or Alzheimer's. You also can't take part if you are pregnant or breastfeeding, or if your doctor thinks there's another medical reason why it wouldn't be safe for you.
For healthy volunteers, you need to be over 18 and generally in good health with no history of cancer. You shouldn't be taking any medication, especially painkillers, in the week before joining, unless the study doctor says it's okay. Everyone taking part needs to be able to understand the study requirements and give their permission to join, and also be part of the French social security system, as the study is based there.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Are you over 18 years old?
- Are you currently being treated for breast, gynaecological, bowel, or lung cancer?
- Have you *not* had cancer or cancer treatment in the past?
- Do you *not* have certain brain tumours or conditions like Parkinson's or Alzheimer's?
- Are you able to understand and cooperate with study instructions?
- Are you not pregnant or breastfeeding?
What does participation involve?
As this study is focused on assessments and doesn't involve new treatments, taking part would primarily involve attending appointments for detailed assessments. These assessments would focus on your thoughts and feelings about pain, as well as your general pain levels. The study is designed to gather information to understand vulnerability, so you wouldn't be given any new medications or specific treatments as part of the study itself. The exact number and duration of visits aren't specified but typically these involve a few appointments over a period to track changes.
Potential risks and benefits
Locations (19)
- Centre Hospitalier d'AjaccioVerified postcodeAjaccio, France· Recruiting
- Centre de Lutte contre le Cancer - Institut de Cancérologie de l'OuestVerified postcodeAngers, France· Recruiting
- Centre Hospitalier Henri Mondor d'AurillacVerified postcodeAurillac, France· Recruiting
- Centre de Lutte contre le Cancer - Institut BergoniéVerified postcodeBordeaux, France· Recruiting
- Centre de Lutte contre le Cancer - Centre François BaclesseVerified postcodeCaen, France· Recruiting
- Centre Hospitalier Universitaire Caen NormandieVerified postcodeCaen, France· Recruiting
- Centre de Lutte contre le Cancer - Jean PerrinVerified postcodeClermont-Ferrand, France· Recruiting
- CHU de Clermont-FerrandVerified postcodeClermont-Ferrand, France· Recruiting
- Hôpitaux civils de ColmarVerified postcodeColmar, France· Recruiting
- Centre Régional de Lutte contre le Cancer - Georges Francois LeclercVerified postcodeDijon, France· Recruiting
- Hôpital privé le BoisVerified postcodeLille, France· Recruiting
- Centre Hospitalier de MontluçonVerified postcodeMontluçon, France· Not yet recruiting
Common questions
What is nerve pain?
Nerve pain, or neuropathic pain, is a type of long-lasting pain caused by damage or injury to the nerves.
Why is this study important?
It's important because it aims to help doctors predict which cancer patients are most likely to get long-lasting nerve pain, so they can offer better support and potentially prevent it.
Will I get new treatment in this study?
No, this study is about understanding pain and predicting risk, not about giving new treatments. Your current cancer treatment will continue as planned.
How long will I need to be involved?
The study description doesn't specify the exact length, but it mentions looking at how pain develops over time, so it would involve a series of assessments over a period.
Can I stop taking part if I change my mind?
Yes, you can choose to leave the study at any point, and it won't affect your ongoing medical care.
How to find out more
Lise LACLAUTRE
Always speak to your GP or specialist before deciding to take part in a study.
Interested in taking part?
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.